MOPI - Malaysian Organisation of Pharmaceutical Industries

🎉 Exciting News! 🎉 MOPI's Pharma Industry Awards 2024 is featured in today's New Straits Times (NST)! 📰✨ You can also access the article here: https://lnkd.in/gMRZCC3v Congratulations once again to all our winners! 👏👏 And a special thank you to the Malaysia Productivity Corporation (MPC) for facilitating this fantastic feature in NST.

📣 Join Us for the Launch of International Healthcare Week 2025! 🌐 MOPI is excited to share that Informa Markets is hosting an official press conference and networking event to launch International Healthcare Week 2025. 📅 Date: 14 October 2024 (Monday) ⏰ Time: 10:00 AM – 1:00 PM 📍 Venue: The Gallery, Level 1A, MITEC, Kuala Lumpur The event will feature insightful presentations on opportunities in Malaysia’s healthcare and pharmaceutical industries, with representatives from MATRADE, AMMI, and MOPI, followed by a networking session. 🔗 Register Here: https://lnkd.in/gW3ttvh6 (Registration is required) About International Healthcare Week 2025: 📅 Date: 16-18 July 2025 This event will bring together three major exhibitions: CPHI South East Asia – Covering the full scope of pharmaceutical production. Medlab Asia – Focusing on medical laboratories and their services. Asia Health – Highlighting healthcare services and advancements in the region. We look forward to seeing you at this exciting launch event!

A Big Thank You to Our Esteemed Guests of Honor at the MOPI Regulatory Plus Conference & Dinner 2024 🌟 We were truly privileged to have the presence of distinguished leaders who contributed to the success of our event. Your participation and insights added immense value to the discussions and celebrations, helping us advance the pharmaceutical landscape in Malaysia. Special thanks to: Dato' Sri Norazman Ayob, Deputy Secretary-General (Finance), Ministry of Health (MOH) Tuan Zahid Ismail, Director General, Malaysia Productivity Corporation (MPC) Puan Norhaliza Binti A Halim, Deputy Director-General of Health (Pharmaceutical Services), MOH Puan Rosilawati Ahmad, Director, National Pharmaceutical Regulatory Agency (NPRA) Encik Mohd Yazid Abdul Majid, Director, Management Services and Technology Division (MMT), MPC We truly appreciate your continued support and leadership in strengthening our local pharmaceutical manufacturing industry. #pharmaceuticals #generics #medicineaccess #medicinesecurity

Celebrating Excellence at the Pharma Industry Awards 2024 🏆 On the memorable night of 19 September 2024, as part of the MOPI Regulatory Plus Conference & Dinner, we proudly hosted the inaugural Pharma Industry Awards—a tribute to the remarkable contributions and achievements within Malaysia’s pharmaceutical manufacturing sector. The prestigious awards were presented by Yang Berusaha Puan Norhaliza Halim, Deputy Director-General of Health (Pharmaceutical Services), Ministry of Health (MOH), Tuan Zahid Ismail, Director General of the Malaysia Productivity Corporation (MPC), alongside Mr. Ch'ng Kien Peng, President of MOPI This night was dedicated to unmasking the true heroes of our industry—those who have set new benchmarks in growth, governance, R&D, and productivity, driving Malaysia’s pharmaceutical landscape forward. Congratulations to the winners: 🏅 Fastest Growing Local Revenue: Hovid Bhd (below RM100M) Kotra Pharma Sdn Bhd (above RM100M) 🏅 Accelerated Export Revenue AIN MEDICARE SDN BHD® (below RM50M) Xepa-Soul Pattinson (Malaysia) Sdn Bhd (above RM50M) 🏅 Investment in Research & Development SM Pharmaceutical Sdn Bhd (below RM100M) Novugen Pharma Sdn Bhd (above RM100M) 🏅 Investment in Capital Assets TIGER BALM (M) SDN BHD (below RM100M) Duopharma Biotech Berhad (above RM100M) 🏅 Highest Productivity (Revenue per Employee) THP Medical Sdn Bhd (Runners-up, OTC) TIGER BALM (M) SDN BHD (Winner, OTC) Duopharma Biotech Berhad (Second Runners-up, Pharmaceuticals) Xepa-Soul Pattinson (Malaysia) Sdn Bhd (Runners-up, Pharmaceuticals) Ranbaxy Malaysia Sdn Bhd (Winner, Pharmaceuticals) To all the winners and participants, your efforts inspire us and raise the bar for the entire industry. Here’s to continued excellence and the bright future of Malaysian pharmaceuticals!

MOPI Regulatory Plus Dinner 2024: Moonlight Masquerade – Unmasking the Heroes of Our Industry 🌙🎭   On the evening of 19 September 2024, we came together for the Moonlight Masquerade, a night dedicated to celebrating the resilience and commitment of those who have been vital to Malaysia's pharmaceutical industry.   This special dinner, part of the MOPI Regulatory Plus Conference & Dinner 2024, was graced by Puan Norhaliza Binti A Halim, Deputy Director-General of Health (Pharmaceutical Services), and symbolized the tireless efforts of local manufacturers who ensured the availability of quality, affordable medicines during the COVID-19 pandemic and continue to safeguard our nation’s healthcare system today.   The Moonlight Masquerade unmasked the true heroes behind the scenes—those who work every day to protect public health, support patient care, and strengthen Malaysia’s pharmaceutical landscape. This evening was a heartfelt tribute to your dedication and ongoing contributions to our industry and country. Thank you for your resilience and for continuing to be the backbone of Malaysia’s healthcare.   #pharmaceuticals #generics #medicineaccess #medicinesecurity

A heartfelt thank you to all the distinguished speakers who made the MOPI Regulatory Plus Conference a success on 19 and 20 September 2024. Your insights and contributions have been instrumental in exploring the regulatory landscape and discussing the future of the generic medicines industry and pharmaceutical manufacturing in Malaysia. Special thanks to our esteemed speakers: Dr. Azuana Binti Ramli – Deputy Director, Centre of Product & Cosmetic Evaluation, National Pharmaceutical Regulatory Agency (NPRA) Mr. Dave Margetts – Chief Executive Officer, Factorytalk Co., Ltd. Mr. Joseph P. Park – Senior Manager, Regulatory Affairs/Regulatory Strategy and Policy, Samsung Bioepis Mr. Devaraj Subramaniam – Associate Principal, Strategy Consulting, IQVIA Malaysia Mr. Arindam Chakrabarti – Associate Vice President, Finance, Biocon Sdn Bhd Mr. Wan Jeffery Majid – Chief Executive Officer - Commercial, Duopharma Biotech Berhad Mr. Rahil Mahmood – Chief Executive Officer, Novugen Pharma Sdn Bhd Mr. Ch'ng Kien Peng – Executive Director, Xepa-Soul Pattinson (Malaysia) Sdn Bhd Ms. Sumathi Balakrishnan – Senior Director, Strategic Negotiations Division, Ministry of Investment, Trade and Industry (MITI) Ms. Suriya Sadanathan – Director of Patents, Adastra IP We truly appreciate the time and effort taken to be with the industry and our stakeholders to share your knowledge and expertise. 🙏 #pharmaceuticals #generics #medicineaccess #medicinesecurity

Honored to have YBhg Dato' Sri Norazman Ayob, Deputy Secretary-General (Finance) from the Ministry Of Health, Malaysia (KKM), officiating the MOPI Regulatory Plus Conference 2024 on 19 September 2024. His presence and insightful opening remarks set the tone for an engaging and productive day, as we delved into key regulatory landscapes and the strategic direction of the Malaysian pharmaceutical industry. Dato' Sri also took the time to visit our sponsor booth exhibitions, engaging with stakeholders and showing support for the key players in the generic and over-the-counter (OTC) medicines sector. Thank you for your leadership and continuous support in enhancing medicine security and ensuring the availability of quality and affordable medicines for all Malaysians. We look forward to continued discussions as we shape the future of the pharmaceutical landscape together. #pharmaceuticals #generics #medicineaccess #medicinesecurity

Happy Malaysia Day – a day that reminds us of the strength in our diversity, unity, and shared aspirations. Together, we continue to build a brighter future for our beloved nation, where every effort counts in driving progress and prosperity. Let’s cherish our heritage and strive for a united Malaysia! 🇲🇾

🎉 Introducing the Pharma Industry Awards 2024! 🎉 We are thrilled to announce the debut of the Pharma Industry Awards 2024, which will be presented during the MOPI Regulatory Plus Dinner on 19 September 2024. These awards will recognize excellence in Malaysia’s pharmaceutical industry, with insights drawn from the MOPI Annual Survey 2023, the MOPI Industry Trends, and The Gold Standard Report. These awards will honor the incredible contributions shaping Malaysia’s healthcare sector and celebrate the continuous pursuit of excellence in local pharmaceutical manufacturing. Join us at the MOPI Regulatory Plus Dinner 2024 to celebrate these milestones. Sign up now: https://lnkd.in/gnbrUrTj

🚨 Final Call! 🚨 Join us for the MOPI Regulatory Plus Conference & Dinner 2024 on 19 & 20 September 2024 at One World Hotel, Petaling Jaya. This is your last chance to register for this pivotal event in the local pharmaceutical industry! 📅 Event Highlights: Conference: National and international speakers on 19 & 20 September. Exhibitions: Showcasing key innovations in the industry. Gala Dinner: Network with peers on 19 September. 📌 Key Topics Covered in the Conference: a) Latest Statistics on the Local Manufacturing Industry b) Regulatory Tomorrow by NPRA c) Digitalization for the Pharmaceutical Industry d) Advancements and Opportunities in Biosimilars e) Establishing Malaysia as a Pharmaceutical Export Hub in ASEAN f) Forum: Advancing the Local Pharmaceutical Industry through Compliance Excellence g) CPTPP - Key Aspects and Opportunities for the Pharmaceutical Industry h) Implementing Patent Linkage in Compliance with CPTPP 🎓 Earn 6 CPD points from the Malaysian Pharmacist Society (MPS). HRDCorp claimable! 👉 Register now: https://lnkd.in/gnbrUrTj 📖 Click on Event Booklet for more information: https://lnkd.in/gsRUmvG2